SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Cowen & Co. Initiates Coverage On Theravance Biopharma with Outperform Rating, Announces Price Target of $42

Cowen & Co. initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Outperform rating and announces Price Target of $42.

Benzinga · 05/13/2020 11:30

Cowen & Co. initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Outperform rating and announces Price Target of $42.